Medicare Advantage: Past, Present, and Future

Carrie Graham, Ph.D. is a Research Professor and the Director of the Medicare Policy Initiative at Georgetown’s Center on Health Insurance Reform (CHIR) where she oversees a portfolio of policy analysis, research and technical assistance for policymakers on Medicare Advantage and original Medicare. Previously she was the Director of Aging and Disability Policy at the Center for Health Care Strategies. She also holds an Adjunct Professor appointment at the University of California, San Francisco, Institute for Health and Aging. Dr. Graham has been working in the field of aging research, health policy, and evaluation research for over 25 years, including evaluating California’s Dual Financial Alignment Initiative and other efforts to expand managed care delivery systems for older adults and people with disabilities. In 2018-2019 she worked as a Health and Aging Policy Fellow in the U.S. House of Representatives, Committee on Ways and Means on Medicare oversight and legislation for post- acute care, surprise billing, and price negotiations for Part D prescription drugs. In 2020 she acted as consultant to California in the development of the state’s Master Plan for Aging; and subsequently provided technical assistance for over 20 states developing their own multisector plans for aging. Dr. Graham holds a doctorate in medical sociology from UCSF and a master’s degree in gerontological studies from the Scripps Gerontology Center at Miami University. She obtained her bachelor’s degree from University of California, San Diego in sociology and African studies.

Brian Miller, M.D., M.B.A., M.P.H. is a practicing hospitalist at the Johns Hopkins Hospital, an Associate Professor of Medicine and Business (courtesy) at Johns Hopkins University, and and a Nonresident Fellow at the American Enterprise Institute. Dr. Miller runs a multi-disciplinary, fifteen-person research group that analyzes market-driven solutions in FDA regulatory policy and Medicare payment policy. Research by his team has been published in The New England Journal of Medicine, JAMA, Tobacco Control, BMJ, and Health Affairs Forefront among other venues. Trained and board-certified in preventive medicine and internal medicine, Dr. Miller has broad regulatory experience at the Centers for Medicare & Medicaid Services, the Federal Trade Commission, the Federal Communications Commission, and the U.S. Food and Drug Administration. Dr. Miller is a Commissioner on the Medicare Payment Advisory Commission, a Trustee for the North Carolina State Health Plan, and a member of the National Advisory Council for the Advancing a Healthier Wisconsin Endowment. He serves as an advisor to members of Congress and other elected officials and lives in Washington, D.C.

-A respected authority on public policy, federal budgeting, and legislative and regulatory strategy, with over 25 years of experience, with a focus on health care, including as a committee health staff director on Capitol Hill shaping policy on Medicare, Medicaid, private insurance and prescription drug pricing and reimbursement issues. -Former chief health advisor for the U.S. Senate Finance Committee, providing strategic counsel to Chairmen Ron Wyden and Max Baucus, and playing a key role in developing and negotiating major health legislation affecting healthcare coverage and reimbursement, delivery system operations and innovation, value and risk assessment, and health outcomes. Empowers clients to anticipate trends, navigate regulatory risks and opportunities, and drive sustainable policy outcomes that align with their business and organizational goals. -Shawn’s health policy experience includes assessing the policy and financial implications of legislative initiatives and advising on trends, regulatory risks and opportunities in public and private sectors. Her understanding of federal health programs enables her to deliver high-level advisory and advocacy services to clients and support them in crafting and implementing health policy, managing regulatory challenges and building bipartisan coalitions that foster lasting outcomes. In her roles on the Senate Finance Committee, Shawn led development of major provisions of the Affordable Care Act, as well as legislation on Medicare prescription drug policies, including Senate Finance Committee passage of the Prescription Drug Pricing Reduction Act of 2019 and enactment of the health provisions included in the Inflation Reduction Act of 2022. Her analytic roles at the Congressional Budget Office and the Centers for Medicare & Medicaid Services further deepens her ability to bring data-driven insights to advise clients on a range of health policy issues. Shawn’s career reflects a commitment to bridging policy goals with practical solutions that drive stakeholder value and improve healthcare delivery and outcomes. Her experience working across the aisle, insights and ability to navigate the full spectrum of the policymaking process positions Shawn to advise clients and achieve results on a range of health care issues.

Jonathan (Jon) Blum is the co-founder and co-Managing Partner of Health Transformation Strategies, a health policy consulting and advisory firm. He is also a Non-Resident Senior Scholar at the USC Schaeffer Institute. More recently, Jon served as the Principal Deputy Administrator and Chief Operating Officer for the Centers for Medicare & Medicaid Services (CMS). In this dual role, Jon led CMS’s program policy planning and implementation and day-to-day operations for the entire agency. Jon also served as CMS’s Deputy Administrator and Director of the Center of Medicare during the Obama Administration, leading the agency’s Medicare payment and delivery reform strategies and the overall management of the Medicare program.